Saturday, Aug 15 2020 | Time 22:46 Hrs(IST)
image
  • All Indians to have health identity: PM
  • Bangladesh Assistant High Commission in Tripura observes 45th death anniversary of Sheikh Mujibur Rahman
  • 306 fresh corona cases witnessed in Aurangabad
  • Covid toll in Bengal stands at 2377; Tally 1,13,432
  • Pakistan vs England: Day 3 play washed out due to rain and bad light
  • Tribals demand for resolving their issues by Freedom Jubilee
  • VP, PM, LS Speaker attend 'At home' hosted by Prez
  • 618 fresh cases of Covid in Marathwada
  • COVID: J&K reports 532 new +ve cases, seven deaths
  • 74th I-Day: COVID shadow dims celebrations; PM talks about heath, self-reliance, security
  • Mamata and her officials' action not in sync with sanctity of occasion : Dhankhar
  • Nagaland detects 18 new COVID-19 in last 24 hrs
  • Meghalaya has clear protocols to contain spread of COVID-19 : Sangma
Business Economy


Yamaha Motor announces accessory campaign for MT-15

Yamaha Motor announces accessory campaign for MT-15

Chennai, May 27 (UNI) India Yamaha Motor (IYM) on Monday announced the accessory campaign for its latest motorcycle MT-15 (155 cc) in India.

The announcement comes in the backdrop of the company’s vision to promote the MT riding culture in India along with the sales and marketing of MT-15 that could match with the global aspiration of

MT motorcyclists by resonating the riding character and personality.

Yamaha introduced its all new motorcycle vertical MT series in India this year with the launch of its

premium motorcycle MT-15 that was defined by its ‘torquey’ and agile handling characteristics along

with the presence of latest technologies outlining the ‘brutal character of the MT’.

Yamaha as part of the brand’s DNA to offer exciting, stylish and sporty products and experiences, has further decided to rejig the excitement by introducing an accessory campaign with the MT-15.

All existing buyers of MT-15 will be contacted by the authorized dealers of IYM to facilitate selection and delivery of complimentary MT branded riding jacket or a helmet along with offering the same to all future buyers at no additional expenses.

The campaign will remain active for a limited period of time.

UNI GV 1733

More News

CEAT announces its association with Mahindra for the launch of THE ALL-NEW THAR

15 Aug 2020 | 6:20 PM

Mumbai, Aug 15 (UNI) CEAT Tyres, India’s leading tyre manufacturer, has announced its association with Mahindra for THE ALL-NEW Mahindra Thar.

see more..
TITA Start-up Community to launch Alap App, alternative for TikTok

TITA Start-up Community to launch Alap App, alternative for TikTok

15 Aug 2020 | 5:56 PM

Hyderabad, Aug 15 (UNI) Telangana Information and Technology Association (TITA) Start-up Community has developed Alap app, a video sharing platform that will be available for netizens by the end of this month.

see more..

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

15 Aug 2020 | 5:51 PM

- Completes first phase in committed investment of US$ 150M ( > INR 1000 Cr)
- Sri KT Rama Rao, Hon'ble Minister for Industry & Commerce and IT, Government of Telangana inaugurates the facility
HYDERABAD, India, Aug. 15, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the inauguration of its new Research and Technology (R&T) Centre in Hyderabad, India. Sri K T Rama Rao, Hon'ble Minister for Industry & Commerce and IT, Government of Telangana formally inaugurated the facility in the presence of other dignitaries.

see more..
CEAT partners with Mahindra for tyre supply of  'Thar'

CEAT partners with Mahindra for tyre supply of 'Thar'

15 Aug 2020 | 5:05 PM

Mumbai, Aug 15 (UNI)Tyre major, CEAT Tyres, announced its association with Mahindra for the all-new Mahindra Thar.

see more..
Lupin presents phase 3 data for solosec demonstrating significant response rate in female patients with trichomoniasis

Lupin presents phase 3 data for solosec demonstrating significant response rate in female patients with trichomoniasis

15 Aug 2020 | 3:00 PM

Mumbai, Aug 14 (UNI) Pharma major Lupin Pharmaceuticals Inc the US based wholly owned subsidiary of Lupin Limited on Saturday announced results from its pivotal Phase 3 clinical trial to assess efficacy and safety of single-dose Solosec® (secnidazole) 2g oral granules in female patients with trichomoniasis, the most common non-viral, curable sexually transmitted infection (STI) in the US.

see more..
image